Wexler William A. 4
4 · Comera Life Sciences Holdings, Inc. · Filed Aug 11, 2022
Insider Transaction Report
Form 4
Wexler William A.
Director
Transactions
- Award
Stock Option (Right to Purchase)
2022-08-09+14,200→ 14,200 totalExercise: $2.77Exp: 2032-08-09→ Common Stock (14,200 underlying)
Footnotes (1)
- [F1]The stock option shall vest over three (3) years, with thirty-three and one-third percent (33 1/3%) of the shares of Common Stock underlying the option vesting on August 9, 2023 and the remainder vesting in equal monthly installments thereafter.